尿道成形术后采用简化多模式阿片类药物最小化疼痛方案可减少阿片类药物处方并维持低疼痛评分
单中心95例接受尿道成形术的男性中,2021年8月前回顾性收集标准疼痛管理(SPM)队列,之后前瞻性研究多模式疼痛管理(MPM)队列。MPM队列阿片类药物处方量较SPM队列减少75吗啡毫克当量(0 vs 75,P<.001),出院阿片类药物处方比例从50%降至11%(P<.001),早期术后疼痛评分低且组间无显著差异,疼痛对生活质量干扰低,并发症罕见。
要点
- MPM队列阿片类药物处方量较SPM队列减少75吗啡毫克当量(0 vs 75,P<.001)。
- 出院阿片类药物处方比例从SPM队列50%降至MPM队列11%(P<.001)。
- 早期术后疼痛评分低且组间无显著差异,疼痛对生活质量干扰低,并发症罕见。
核心结论
- 该简化多模式镇痛方案有效减少尿道成形术后阿片类药物发放,且不影响生活质量结局。
- 该疼痛方案可易于采用以减少尿道成形术男性的术后阿片类药物使用。
研究设计与样本
- 单中心95例男性于2020年10月至2023年10月接受尿道成形术。
- 回顾性审查2021年8月前标准疼痛管理(SPM)队列,前瞻性研究2021年8月后多模式疼痛管理(MPM)队列。
- SPM队列从电子病历收集术后第1天疼痛评分,MPM队列在术后早期获取经验证的疼痛和生活质量评估。
- SPM队列术后第1天疼痛评分与MPM队列术后第2天疼痛评分比较。
- 从处方监测项目查询阿片类药物发放记录。
主要发现
- MPM队列阿片类药物处方量较SPM队列减少75吗啡毫克当量(0(四分位距[IQR]:0-0) vs 75(IQR:0-150),P < .001)。
- 出院阿片类药物处方患者比例从SPM队列50%降至MPM队列11%(P < .001)。
- 早期术后疼痛评分保持低水平,队列间无显著差异。
- 疼痛对生活质量测量的干扰保持低水平。
- 两个队列并发症均罕见。
临床怎么用
- 作者认为该简化多模式镇痛方案可易于采用以减少尿道成形术男性的术后阿片类药物使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To implement a simplified, opioid-minimized, multimodal pain management (MPM) protocol and assess its effectiveness of reducing opioid dispersion while maintaining low postoperative complications, patient-reported pain, and patient-reported interference with quality of life (QOL) for men undergoing urethroplasty. METHODS: Ninety-five men at a single academic center from October 2020 to October 2023 received a urethroplasty. We retrospectively reviewed the prior standard pain management (SPM) cohort before August 2021, then prospectively studied the MPM cohort after August 2021. For the SPM cohort, we collected postoperative day (POD) 1 pain scores from our Electronic Medical Record (EMR). For the MPM cohort, we obtained a validated pain and QOL assessment in the early postoperative period. The SPM cohort's POD 1 pain scores were compared with the MPM cohort's POD 2 pain scores. Opioid dispensation records were queried from the Prescription Monitoring Program. RESULTS: Seventy-five morphine milligram equivalent fewer opioids in the MPM cohort were prescribed than the SPM cohort (0 (interquartile range [IQR]: 0-0) vs 75 (IQR:0-150), P < .001, respectively). Patients with opioid discharge prescriptions fell from 50% in the SPM cohort to 11% in the MPM cohort (P < .001). Early postoperative pain scores remained low and showed no significant difference between the cohorts. Pain's interference with QOL measures remained low. Complications were rare across both cohorts. CONCLUSION: This simplified, multimodal analgesia protocol effectively decreases postoperative pain and opioid dispersion without affecting QOL outcomes after urethroplasty. This pain regimen can be easily adopted to decrease the use of postoperative opioids in men undergoing urethroplasty.
引用
- Butler I, Taheri P, Khanna P, et al. Decreased Opioid Prescription With Low Pain Scores After Urethroplasty: Using a Simplified, Multimodal, Opioid Minimization Pain Protocol. Urology. 2024. PMID: 38367712. doi:10.1016/j.urology.2024.01.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。